Furthermore, the evaluation of IGA1 and IGA2 expression and localization by immunohistochemistry in human AAA and control aortas revealed a strong staining in the pathological arteries, while only a faint signal was detected in the healthy aortas (Fig. 2B). This evidence concerns the gene IGHA1 and triple-A syndrome.